Movement Disorders Clinical Trials

Find Movement Disorders Clinical Trials Near You

Impact of Theta Burst Repetitive Transcranial Magnetic Stimulation on the Patient's Self-reported Improvement in Their Motor Functional Neurological Disorder

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Functional neurological disorder (FND) is a condition that causes significant suffering and disability. It is defined by the presence of neurological symptoms that interfere with an individual's functioning and are not consistent with any known anatomical lesion but that causes significant functional impairment. We are particularly interested in motor symptoms (abnormal movements or motor deficits). Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive and acceptable treatment that has proven effective in certain chronic pain conditions, depression, and OCD. We would like to evaluate the impact of rTMS on the patient's overall perception of change, particularly on the clinical symptoms of motor FND. Secondary objectives include evaluating the overall effect on symptoms from the clinician's perspective, the effect on quality of life, on depressive and anxiety symptoms and associated dissociation, as well as evaluating any changes in the sense of agency and identifying the side effects of rTMS treatment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients over 18

• Patients with FND, either deficits or abnormal movements, diagnosed by a neurologist.

• Patients with an indication for validated neuronavigated rTMS treatment.

• Patients who have indicated that they do not object to participating in the study.

Locations
Other Locations
France
Centre Hospitalier Guillaume Régnier
RECRUITING
Rennes
Contact Information
Primary
Dominique DRAPIER, PHD
d.drapier@ch-guillaumeregnier.fr
+332 99 33 39 37
Time Frame
Start Date: 2026-03-13
Estimated Completion Date: 2028-03
Participants
Target number of participants: 22
Sponsors
Leads: Hospital Center Guillaume Régnier

This content was sourced from clinicaltrials.gov